Bafna Pharmaceuticals Limited's total assets for Q2 2026 were ₹1.61B, an increase of Infinity% from the previous quarter. IN:BAFNAPH total liabilities were ₹694.55M for the fiscal quarter, a -181.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.